# Cancer Biology and Therapeutics
# Part I: Fundamentals of Cancer 
## Chapter 1: The Building Blocks of Life: Normal Cell Biology

<details>
<summary><strong>1.1 Introduction to Cells</strong></summary>
<br>

- [View Section](./Chapter%2001:%20The%20Building%20Blocks%20of%20Life:%20Normal%20Cell%20Biology.md#11-introduction-to-cells)

</details>

<details>
<summary><strong>1.2 Cellular Organelles and Their Functions</strong></summary>
<br>

- [View Main Section](./Chapter%2001:%20The%20Building%20Blocks%20of%20Life:%20Normal%20Cell%20Biology.md#12-cellular-organelles-and-their-functions)
- **1.2.1** [Nucleus](./Chapter%2001:%20The%20Building%20Blocks%20of%20Life:%20Normal%20Cell%20Biology.md#121-nucleus)
- **1.2.2** [Ribosomes](./Chapter%2001:%20The%20Building%20Blocks%20of%20Life:%20Normal%20Cell%20Biology.md#122-ribosomes)
- **1.2.3** [Endoplasmic Reticulum (ER)](./Chapter%2001:%20The%20Building%20Blocks%20of%20Life:%20Normal%20Cell%20Biology.md#123-endoplasmic-reticulum-er)
- **1.2.4** [Golgi Apparatus](./Chapter%2001:%20The%20Building%20Blocks%20of%20Life:%20Normal%20Cell%20Biology.md#124-golgi-apparatus)
- **1.2.5** [Mitochondria](./Chapter%2001:%20The%20Building%20Blocks%20of%20Life:%20Normal%20Cell%20Biology.md#125-mitochondria)

</details>

<details>
<summary><strong>1.3 The Cell Cycle: Growth, Division, and Regulation</strong></summary>
<br>

- [View Main Section](./Chapter%2001:%20The%20Building%20Blocks%20of%20Life:%20Normal%20Cell%20Biology.md#13-the-cell-cycle-growth-division-and-regulation)
- **1.3.1** [Phases of the Cell Cycle](./Chapter%2001:%20The%20Building%20Blocks%20of%20Life:%20Normal%20Cell%20Biology.md#131-phases-of-the-cell-cycle)
- **1.3.2** [Regulation of the Cell Cycle](./Chapter%2001:%20The%20Building%20Blocks%20of%20Life:%20Normal%20Cell%20Biology.md#132-regulation-of-the-cell-cycle)
- **1.3.3** [Cell Cycle Dysregulation in Cancer](./Chapter%2001:%20The%20Building%20Blocks%20of%20Life:%20Normal%20Cell%20Biology.md#133-cell-cycle-dysregulation-in-cancer)

</details>

<details>
<summary><strong>1.4 DNA, RNA, and Protein Synthesis</strong></summary>
<br>

- [View Main Section](./Chapter%2001:%20The%20Building%20Blocks%20of%20Life:%20Normal%20Cell%20Biology.md#14-dna-rna-and-protein-synthesis)
- **1.4.1** [DNA Structure and Organization](./Chapter%2001:%20The%20Building%20Blocks%20of%20Life:%20Normal%20Cell%20Biology.md#141-dna-structure-and-organization)
- **1.4.2** [DNA Replication](./Chapter%2001:%20The%20Building%20Blocks%20of%20Life:%20Normal%20Cell%20Biology.md#142-dna-replication)
- **1.4.3** [Transcription: From DNA to RNA](./Chapter%2001:%20The%20Building%20Blocks%20of%20Life:%20Normal%20Cell%20Biology.md#143-transcription-from-dna-to-rna)
- **1.4.4** [Translation: From RNA to Protein](./Chapter%2001:%20The%20Building%20Blocks%20of%20Life:%20Normal%20Cell%20Biology.md#144-translation-from-rna-to-protein)

</details>

<details>
<summary><strong>1.5 Cell Communication and Signaling Pathways</strong></summary>
<br>

- [View Section](./Chapter%2001:%20The%20Building%20Blocks%20of%20Life:%20Normal%20Cell%20Biology.md#15-cell-communication-and-signaling-pathways)

</details>

<details>
<summary><strong>1.6 Tissue Organization and Organ Systems</strong></summary>
<br>

- [View Section](./Chapter%2001:%20The%20Building%20Blocks%20of%20Life:%20Normal%20Cell%20Biology.md#16-tissue-organization-and-organ-systems)

</details>

<details>
<summary><strong>1.7 Cell Death: Apoptosis and Necrosis</strong></summary>
<br>

- [View Main Section](./Chapter%2001:%20The%20Building%20Blocks%20of%20Life:%20Normal%20Cell%20Biology.md#17-cell-death-apoptosis-and-necrosis)
- **1.7.1** [Apoptosis: Programmed Cell Death](./Chapter%2001:%20The%20Building%20Blocks%20of%20Life:%20Normal%20Cell%20Biology.md#171-apoptosis-programmed-cell-death)
  - [Molecular Mechanisms of Apoptosis](./Chapter%2001:%20The%20Building%20Blocks%20of%20Life:%20Normal%20Cell%20Biology.md#molecular-mechanisms-of-apoptosis)
  - [Regulation of Apoptosis](./Chapter%2001:%20The%20Building%20Blocks%20of%20Life:%20Normal%20Cell%20Biology.md#regulation-of-apoptosis)
- **1.7.2** [Necrosis: Uncontrolled Cell Death](./Chapter%2001:%20The%20Building%20Blocks%20of%20Life:%20Normal%20Cell%20Biology.md#172-necrosis-uncontrolled-cell-death)

</details>

<details>
<summary><strong>1.8 Cancer: Disruption of Normal Cell Biology</strong></summary>
<br>

- [View Main Section](./Chapter%2001:%20The%20Building%20Blocks%20of%20Life:%20Normal%20Cell%20Biology.md#18-cancer-disruption-of-normal-cell-biology)
- **1.8.1** [Cancer as a Microevolutionary Process](./Chapter%2001:%20The%20Building%20Blocks%20of%20Life:%20Normal%20Cell%20Biology.md#181-cancer-as-a-microevolutionary-process)
- **1.8.2** [Properties of Cancer Cells](./Chapter%2001:%20The%20Building%20Blocks%20of%20Life:%20Normal%20Cell%20Biology.md#182-properties-of-cancer-cells)
- **1.8.3** [Cancer Development](./Chapter%2001:%20The%20Building%20Blocks%20of%20Life:%20Normal%20Cell%20Biology.md#183-cancer-development)
- **1.8.4** [Genetic Instability in Cancer](./Chapter%2001:%20The%20Building%20Blocks%20of%20Life:%20Normal%20Cell%20Biology.md#184-genetic-instability-in-cancer)

</details>

<details>
<summary><strong>Summary</strong></summary>
<br>

- [View Summary](./Chapter%2001:%20The%20Building%20Blocks%20of%20Life:%20Normal%20Cell%20Biology.md#summary)

</details>

## Chapter 2: Introduction to Cancer: A Disease of Deregulation

<details>
<summary><strong>2.1 Defining Cancer: Uncontrolled Growth and Invasion</strong></summary>
<br>

- [View Main Section](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#21-defining-cancer-uncontrolled-growth-and-invasion)
- **2.1.1** [Cancer as a Cellular Disease](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#211-cancer-as-a-cellular-disease)
- **2.1.2** [The Multistep Process of Carcinogenesis](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#212-the-multistep-process-of-carcinogenesis)
- **2.1.3** [Distinguishing Characteristics of Malignancy](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#213-distinguishing-characteristics-of-malignancy)
- **2.1.4** [Cancer as a Systemic Disease](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#214-cancer-as-a-systemic-disease)
  - [The Systemic Nature of Cancer](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#the-systemic-nature-of-cancer)
  - [Mechanisms of Systemic Disease](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#mechanisms-of-systemic-disease)

</details>

<details>
<summary><strong>2.2 History of Cancer Research</strong></summary>
<br>

- [View Main Section](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#22-history-of-cancer-research)
- **2.2.1** [Ancient Origins and Early Documentation](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#221-ancient-origins-and-early-documentation)
  - [Ancient Egyptian Medicine](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#ancient-egyptian-medicine)
  - [Paleropathological Evidence](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#paleropathological-evidence)
- **2.2.2** [Greek and Roman Contributions](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#222-greek-and-roman-contributions)
  - [Hippocrates: The Father of Medicine](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#hippocrates-the-father-of-medicine)
  - [Roman Medicine and Celsus](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#roman-medicine-and-celsus)
  - [Galen's Influence](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#galens-influence)
- **2.2.3** [Medieval Medicine and Islamic Contributions](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#223-medieval-medicine-and-islamic-contributions)
  - [The Golden Age of Islamic Medicine](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#the-golden-age-of-islamic-medicine)
  - [Key Islamic Physicians and Cancer Understanding](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#key-islamic-physicians-and-cancer-understanding)
  - [Medieval Disease Concepts](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#medieval-disease-concepts)
- **2.2.4** [The Renaissance Revolution](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#224-the-renaissance-revolution)
  - [Challenging Ancient Authorities](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#challenging-ancient-authorities)
  - [Andreas Vesalius and Anatomical Revolution](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#andreas-vesalius-and-anatomical-revolution)
  - [William Harvey and Circulation](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#william-harvey-and-circulation)
- **2.2.5** [The Rise of Scientific Pathology (19th Century)](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#225-the-rise-of-scientific-pathology-19th-century)
  - [Rudolf Virchow and Cellular Pathology](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#rudolf-virchow-and-cellular-pathology)
  - [The Impact of Microscopy](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#the-impact-of-microscopy)
  - [Cell Theory and Cancer](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#cell-theory-and-cancer)
- **2.2.6** [The 20th Century: Institutional Development](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#226-the-20th-century-institutional-development)
  - [Early 20th Century Context](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#early-20th-century-context)
  - [The National Cancer Institute Era](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#the-national-cancer-institute-era)
- **2.2.7** [The War on Cancer: The National Cancer Act of 1971](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#227-the-war-on-cancer-the-national-cancer-act-of-1971)
  - [Political and Social Context](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#political-and-social-context)
  - [The Act's Provisions and Impact](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#the-acts-provisions-and-impact)
  - [Key Achievements](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#key-achievements)
  - [Scientific Infrastructure Development](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#scientific-infrastructure-development)
- **2.2.8** [Modern Era and Future Directions](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#228-modern-era-and-future-directions)
  - [Contemporary Achievements](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#contemporary-achievements)
  - [Continuing Challenges and Opportunities](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#continuing-challenges-and-opportunities)

</details>

<details>
<summary><strong>2.3 Hallmarks of Cancer</strong></summary>
<br>

- [View Main Section](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#23-hallmarks-of-cancer)
- **2.3.1** [The Original Six Hallmarks](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#231-the-original-six-hallmarks)
- **2.3.2** [The Next Generation: Updated Hallmarks](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#232-the-next-generation-updated-hallmarks)
- **2.3.3** [Emerging Hallmarks and Enabling Characteristics](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#233-emerging-hallmarks-and-enabling-characteristics)
- **2.3.4** [Clinical and Research Implications](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#234-clinical-and-research-implications)

</details>

<details>
<summary><strong>2.4 Terminology in Oncology</strong></summary>
<br>

- [View Main Section](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#24-terminology-in-oncology)
- **2.4.1** [Classification of Neoplasms](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#241-classification-of-neoplasms)
  - [Benign vs. Malignant Tumors](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#benign-vs-malignant-tumors)
  - [Tissue of Origin Classification](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#tissue-of-origin-classification)
- **2.4.2** [Grading and Differentiation](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#242-grading-and-differentiation)
- **2.4.3** [Staging Systems](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#243-staging-systems)
  - [TNM Components](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#tnm-components)
  - [Stage Grouping](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#stage-grouping)
- **2.4.4** [Patterns of Metastatic Spread](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#244-patterns-of-metastatic-spread)
  - [Routes of Spread](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#routes-of-spread)
  - [Common Metastatic Sites](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#common-metastatic-sites)

</details>

<details>
<summary><strong>2.5 Epidemiology of Cancer</strong></summary>
<br>

- [View Main Section](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#25-epidemiology-of-cancer)
- **2.5.1** [Global Cancer Burden](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#251-global-cancer-burden)
- **2.5.2** [Risk Factors for Cancer](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#252-risk-factors-for-cancer)
  - [Major Modifiable Risk Factors](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#major-modifiable-risk-factors)
  - [Environmental and Occupational Risk Factors](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#environmental-and-occupational-risk-factors)
  - [Non-Modifiable Risk Factors](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#non-modifiable-risk-factors)
- **2.5.3** [Cancer Prevention and Screening](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#253-cancer-prevention-and-screening)
  - [Primary Prevention](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#primary-prevention)
  - [Secondary Prevention (Screening)](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#secondary-prevention-screening)
  - [Established Screening Programs](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#established-screening-programs)
  - [Challenges in Cancer Prevention and Screening](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#challenges-in-cancer-prevention-and-screening)
  - [Future Directions in Cancer Prevention](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#future-directions-in-cancer-prevention)
- **2.5.4** [Cancer Survivorship](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#254-cancer-survivorship)

</details>

<details>
<summary><strong>Summary</strong></summary>
<br>

- [View Summary](./Chapter%2002:%20Introduction%20to%20Cancer:%20A%20Disease%20of%20Deregulation.md#summary)

</details>

## Chapter 3: Cancer Epidemiology and Risk Factors

<details>
<summary><strong>3.1 Global Cancer Incidence and Mortality</strong></summary>
<br>

- [View Main Section](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#31-global-cancer-incidence-and-mortality)
- **3.1.1** [Current Global Cancer Burden](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#311-current-global-cancer-burden)
  - [Contemporary Global Cancer Statistics](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#contemporary-global-cancer-statistics)
  - [Leading Cancer Types Globally](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#leading-cancer-types-globally)
  - [Regional Distribution of Cancer Burden](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#regional-distribution-of-cancer-burden)
  - [Human Development Index and Cancer Patterns](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#human-development-index-and-cancer-patterns)
  - [Future Projections](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#future-projections)
- **3.1.2** [Regional Variations in Cancer Burden](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#312-regional-variations-in-cancer-burden)
- **3.1.3** [Temporal Trends in Cancer Incidence and Mortality](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#313-temporal-trends-in-cancer-incidence-and-mortality)
  - [Overall Trends in Cancer Incidence and Mortality](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#overall-trends-in-cancer-incidence-and-mortality)
  - [Site-Specific Temporal Patterns](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#site-specific-temporal-patterns)
  - [Socioeconomic Patterns in Temporal Trends](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#socioeconomic-patterns-in-temporal-trends)
  - [Factors Driving Temporal Changes](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#factors-driving-temporal-changes)
- **3.1.4** [Cancer Surveillance and Monitoring Systems](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#314-cancer-surveillance-and-monitoring-systems)
  - [Population-Based Cancer Registries](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#population-based-cancer-registries)
  - [International Collaborative Efforts](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#international-collaborative-efforts)
  - [Data Quality Challenges](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#data-quality-challenges)

</details>

<details>
<summary><strong>3.2 Genetic vs. Environmental Contributions</strong></summary>
<br>

- [View Main Section](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#32-genetic-vs-environmental-contributions)
- **3.2.1** [Frameworks for Understanding Cancer Causation](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#321-frameworks-for-understanding-cancer-causation)
  - [Multifactorial Models of Disease](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#multifactorial-models-of-disease)
  - [Gene-Environment Interactions](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#gene-environment-interactions)
- **3.2.2** [Evidence for Genetic Contributions](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#322-evidence-for-genetic-contributions)
  - [Family Studies and Hereditary Risk](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#family-studies-and-hereditary-risk)
  - [High-Penetrance Cancer Susceptibility Genes](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#high-penetrance-cancer-susceptibility-genes)
  - [Moderate and Low-Penetrance Variants](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#moderate-and-low-penetrance-variants)
- **3.2.3** [Evidence for Environmental Contributions](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#323-evidence-for-environmental-contributions)
  - [Gene-Environment Interaction Framework](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#gene-environment-interaction-framework)
  - [Environmental Exposure Significance](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#environmental-exposure-significance)
  - [Mechanistic Understanding](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#mechanistic-understanding)
  - [Complex Interaction Patterns](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#complex-interaction-patterns)
  - [Examples of Gene-Environment Interactions](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#examples-of-gene-environment-interactions)
  - [Air Pollution and Cancer](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#air-pollution-and-cancer)
- **3.2.4** [Integrating Genetic and Environmental Factors](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#324-integrating-genetic-and-environmental-factors)
  - [Gene-Environment Interaction Research](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#gene-environment-interaction-research)
  - [Molecular Epidemiology Approaches](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#molecular-epidemiology-approaches)

</details>

<details>
<summary><strong>3.3 Lifestyle-Associated Cancers</strong></summary>
<br>

- [View Main Section](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#33-lifestyle-associated-cancers)
- **3.3.1** [Tobacco Use](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#331-tobacco-use)
  - [Epidemiological Evidence](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#epidemiological-evidence)
  - [Carcinogenic Mechanisms](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#carcinogenic-mechanisms)
  - [Secondhand Smoke](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#secondhand-smoke)
- **3.3.2** [Physical Activity and Obesity](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#332-physical-activity-and-obesity)
  - [Physical Activity and Cancer Risk](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#physical-activity-and-cancer-risk)
  - [Mechanisms](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#mechanisms)
- **3.3.3** [Diet and Nutrition](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#333-diet-and-nutrition)
  - [Dietary Risk Factors](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#dietary-risk-factors)
  - [Nutritional Epidemiology](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#nutritional-epidemiology)

</details>

<details>
<summary><strong>3.4 Environmental and Occupational Cancer Risks</strong></summary>
<br>

- [View Main Section](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#34-environmental-and-occupational-cancer-risks)
- [Scope of Environmental and Occupational Carcinogens](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#scope-of-environmental-and-occupational-carcinogens)
- [Global Burden of Occupational Cancer](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#global-burden-of-occupational-cancer)
- [Environmental Carcinogen Burden](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#environmental-carcinogen-burden)
- [Specific Occupational Carcinogens](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#specific-occupational-carcinogens)
- [Environmental Exposure Routes and Sources](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#environmental-exposure-routes-and-sources)
- [Challenges in Environmental Carcinogen Research](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#challenges-in-environmental-carcinogen-research)
- [Complex Mixtures and Emerging Concerns](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#complex-mixtures-and-emerging-concerns)

</details>

<details>
<summary><strong>3.5 Cancer Health Disparities and Social Determinants</strong></summary>
<br>

- [View Main Section](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#35-cancer-health-disparities-and-social-determinants)
- [Framework for Understanding Cancer Disparities](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#framework-for-understanding-cancer-disparities)
- [Racial and Ethnic Disparities](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#racial-and-ethnic-disparities)
- [Social Determinants of Health](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#social-determinants-of-health)
- [Healthcare Access and Quality](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#healthcare-access-and-quality)
- [Biological and Genetic Factors](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#biological-and-genetic-factors)
- [Consequences of Disparities](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#consequences-of-disparities)

</details>

<details>
<summary><strong>Conclusion</strong></summary>
<br>

- [View Conclusion](./Chapter%2003:%20Cancer%20Epidemiology%20and%20Risk%20Factors.md#conclusion)

</details>

# Part II: The Molecular and Genetic Basis of Cancer

## Chapter 4: Genetics and Genomic Instability in Cancer

<details>
<summary><strong>4.1 DNA Structure and Replication</strong></summary>
<br>

- [View Main Section](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#41-dna-structure-and-replication)
- **4.1.1** [DNA Structure and Organization](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#411-dna-structure-and-organization)
  - [Nucleotides and Base Pairing](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#nucleotides-and-base-pairing)
  - [DNA Packaging in Chromosomes](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#dna-packaging-in-chromosomes)
  - [Chromatin Organization](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#chromatin-organization)
- **4.1.2** [DNA Replication Process](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#412-dna-replication-process)
  - [Replication Initiation](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#replication-initiation)
  - [The Replication Fork](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#the-replication-fork)
  - [Leading and Lagging Strands](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#leading-and-lagging-strands)
  - [Okazaki Fragments](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#okazaki-fragments)
- **4.1.3** [Accuracy of DNA Replication](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#413-accuracy-of-dna-replication)
  - [Proofreading Mechanisms](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#proofreading-mechanisms)
- **4.1.4** [DNA Replication and Cancer](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#414-dna-replication-and-cancer)
  - [Fundamental Relationship Between DNA Replication and Cancer](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#fundamental-relationship-between-dna-replication-and-cancer)
  - [Replication Stress and Genomic Instability](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#replication-stress-and-genomic-instability)
  - [Oncogene-Induced Replication Stress](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#oncogene-induced-replication-stress)
  - [Mechanisms of Replication-Associated DNA Damage](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#mechanisms-of-replication-associated-dna-damage)
  - [Common Fragile Sites and Cancer](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#common-fragile-sites-and-cancer)
  - [Cell Cycle Control and Genomic Stability](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#cell-cycle-control-and-genomic-stability)
  - [Clinical Implications of Replication Defects](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#clinical-implications-of-replication-defects)

</details>

<details>
<summary><strong>4.2 Mutations: Types and Consequences</strong></summary>
<br>

- [View Main Section](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#42-mutations-types-and-consequences)
- **4.2.1** [Types of Mutations](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#421-types-of-mutations)
  - [Point Mutations](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#point-mutations)
  - [Spontaneous Mutations](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#spontaneous-mutations)
  - [Induced Mutations](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#induced-mutations)
- **4.2.2** [Functional Consequences of Mutations](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#422-functional-consequences-of-mutations)
  - [Classification of Functional Mutation Effects](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#classification-of-functional-mutation-effects)
  - [Gain-of-Function Mutations and Oncogenes](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#gain-of-function-mutations-and-oncogenes)
  - [Mechanisms of Oncogene Activation](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#mechanisms-of-oncogene-activation)
  - [Loss-of-Function Mutations and Tumor Suppressors](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#loss-of-function-mutations-and-tumor-suppressors)
  - [The Two-Hit Hypothesis](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#the-two-hit-hypothesis)
  - [Key Tumor Suppressor Mechanisms](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#key-tumor-suppressor-mechanisms)
  - [Structural Impact of Cancer Mutations](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#structural-impact-of-cancer-mutations)
  - [Complex Tumor Suppressor Functions](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#complex-tumor-suppressor-functions)
- **4.2.3** [Somatic Mutations in Cancer](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#423-somatic-mutations-in-cancer)
  - [Accumulation of Somatic Mutations](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#accumulation-of-somatic-mutations)
  - [Cancer Development Through Mutations](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#cancer-development-through-mutations)
- **4.2.4** [Mutation Rates and Cancer Risk](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#424-mutation-rates-and-cancer-risk)

</details>

<details>
<summary><strong>4.3 Chromosomal Abnormalities</strong></summary>
<br>

- [View Main Section](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#43-chromosomal-abnormalities)
- [Overview of Chromosomal Abnormalities in Cancer](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#overview-of-chromosomal-abnormalities-in-cancer)
- [Types and Prevalence of Chromosomal Abnormalities](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#types-and-prevalence-of-chromosomal-abnormalities)
- [Mechanisms Underlying Chromosomal Instability](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#mechanisms-underlying-chromosomal-instability)
- [Impact on Gene Expression and Function](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#impact-on-gene-expression-and-function)
- [Patterns and Progression of Chromosomal Changes](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#patterns-and-progression-of-chromosomal-changes)
- [Chromosomal Instability Syndromes](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#chromosomal-instability-syndromes)
- [Clinical Detection and Significance](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#clinical-detection-and-significance)
- [Chromosomal Abnormalities and Treatment Resistance](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#chromosomal-abnormalities-and-treatment-resistance)
- [Molecular Cytogenetic Detection Methods](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#molecular-cytogenetic-detection-methods)
- [Specific Cancer Types and Chromosomal Patterns](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#specific-cancer-types-and-chromosomal-patterns)
- [Evolutionary Implications](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#evolutionary-implications)
- [Diagnostic and Prognostic Implications](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#diagnostic-and-prognostic-implications)

</details>

<details>
<summary><strong>4.4 DNA Repair Mechanisms and Their Failure in Cancer</strong></summary>
<br>

- [View Main Section](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#44-dna-repair-mechanisms-and-their-failure-in-cancer)
- **4.4.1** [Overview of DNA Damage](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#441-overview-of-dna-damage)
- **4.4.2** [Major DNA Repair Pathways](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#442-major-dna-repair-pathways)
  - [Base Excision Repair](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#base-excision-repair)
  - [Nucleotide Excision Repair](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#nucleotide-excision-repair)
  - [Mismatch Repair](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#mismatch-repair)
  - [Double-Strand Break Repair](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#double-strand-break-repair)
- **4.4.4** [DNA Repair Defects and Cancer](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#444-dna-repair-defects-and-cancer)
  - [Hereditary Cancer Syndromes](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#hereditary-cancer-syndromes)
  - [Xeroderma Pigmentosum](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#xeroderma-pigmentosum)
  - [Clinical Significance](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#clinical-significance)
- **4.4.5** [DNA Repair Surveillance](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#445-dna-repair-surveillance)

</details>

<details>
<summary><strong>4.5 Genomic Instability</strong></summary>
<br>

- [View Main Section](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#45-genomic-instability)
- **4.5.1** [Cancer as an Evolutionary Process](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#451-cancer-as-an-evolutionary-process)
  - [Evidence for Somatic Evolution](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#evidence-for-somatic-evolution)
- **4.5.2** [Types of Genomic Instability](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#452-types-of-genomic-instability)
  - [Chromosomal Instability](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#chromosomal-instability)
  - [Microsatellite Instability](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#microsatellite-instability)
- **4.5.3** [Mechanisms Driving Genomic Instability](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#453-mechanisms-driving-genomic-instability)
  - [p53 Loss and Chromosomal Instability](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#p53-loss-and-chromosomal-instability)
  - [Telomere Dysfunction](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#telomere-dysfunction)
- **4.5.4** [Genomic Landscape of Cancer](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#454-genomic-landscape-of-cancer)
  - [Driver vs Passenger Mutations](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#driver-vs-passenger-mutations)
- **4.5.5** [Clinical Implications of Genomic Instability](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#455-clinical-implications-of-genomic-instability)
  - [Cancer Progression](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#cancer-progression)
  - [Therapeutic Considerations](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#therapeutic-considerations)

</details>

<details>
<summary><strong>Summary</strong></summary>
<br>

- [View Summary](./Chapter%2004:%20Genetics%20and%20Genomic%20Instability%20in%20Cancer.md#summary)

</details>

## Chapter 5: Oncogenes

<details>
<summary><strong>5.1 Discovery of Oncogenes</strong></summary>
<br>

- [View Main Section](./Chapter%2005:%20Oncogenes.md#51-discovery-of-oncogenes)
- **5.1.1** [Viral Oncogenes and Retroviral Discoveries](./Chapter%2005:%20Oncogenes.md#511-viral-oncogenes-and-retroviral-discoveries)
  - [Peyton Rous and Early Virus Discovery](./Chapter%2005:%20Oncogenes.md#peyton-rous-and-early-virus-discovery)
  - [Retroviral Life Cycle and Transformation](./Chapter%2005:%20Oncogenes.md#retroviral-life-cycle-and-transformation)
- **5.1.2** [Discovery of Viral Oncogenes and Proto-oncogenes](./Chapter%2005:%20Oncogenes.md#512-discovery-of-viral-oncogenes-and-proto-oncogenes)
  - [First Viral Oncogenes](./Chapter%2005:%20Oncogenes.md#first-viral-oncogenes)
  - [Discovery of Cellular Origins](./Chapter%2005:%20Oncogenes.md#discovery-of-cellular-origins)
  - [Retroviral Transduction Process](./Chapter%2005:%20Oncogenes.md#retroviral-transduction-process)
- **5.1.3** [Mechanisms of Proto-oncogene Activation](./Chapter%2005:%20Oncogenes.md#513-mechanisms-of-proto-oncogene-activation)
  - [Insertional Mutagenesis](./Chapter%2005:%20Oncogenes.md#insertional-mutagenesis)
  - [Structural Alterations in Viral Oncogenes](./Chapter%2005:%20Oncogenes.md#structural-alterations-in-viral-oncogenes)
- **5.1.4** [From Viral Studies to Human Cancer](./Chapter%2005:%20Oncogenes.md#514-from-viral-studies-to-human-cancer)
  - [Chromosomal Translocations as Guides](./Chapter%2005:%20Oncogenes.md#chromosomal-translocations-as-guides)
  - [Human Oncogene Identification](./Chapter%2005:%20Oncogenes.md#human-oncogene-identification)

</details>

<details>
<summary><strong>5.2 Proto-oncogenes: Normal Cellular Functions</strong></summary>
<br>

- [View Main Section](./Chapter%2005:%20Oncogenes.md#52-proto-oncogenes-normal-cellular-functions)
- **5.2.1** [Cellular Functions of Proto-oncogenes](./Chapter%2005:%20Oncogenes.md#521-cellular-functions-of-proto-oncogenes)
  - [Signal Transduction Components](./Chapter%2005:%20Oncogenes.md#signal-transduction-components)
  - [Cell Cycle and Growth Control](./Chapter%2005:%20Oncogenes.md#cell-cycle-and-growth-control)
- **5.2.2** [Major Proto-oncogene Families](./Chapter%2005:%20Oncogenes.md#522-major-proto-oncogene-families)
  - [Growth Factor Receptors](./Chapter%2005:%20Oncogenes.md#growth-factor-receptors)
  - [Signal Transduction Molecules](./Chapter%2005:%20Oncogenes.md#signal-transduction-molecules)
  - [Transcriptional Regulators](./Chapter%2005:%20Oncogenes.md#transcriptional-regulators)
- **5.2.3** [Normal Regulation of Proto-oncogenes](./Chapter%2005:%20Oncogenes.md#523-normal-regulation-of-proto-oncogenes)

</details>

<details>
<summary><strong>5.3 Mechanisms of Oncogene Activation</strong></summary>
<br>

- [View Main Section](./Chapter%2005:%20Oncogenes.md#53-mechanisms-of-oncogene-activation)
- **5.3.1** [Point Mutations](./Chapter%2005:%20Oncogenes.md#531-point-mutations)
  - [RAS Mutations](./Chapter%2005:%20Oncogenes.md#ras-mutations)
  - [Other Mutation Examples](./Chapter%2005:%20Oncogenes.md#other-mutation-examples)
- **5.3.2** [Gene Amplification](./Chapter%2005:%20Oncogenes.md#532-gene-amplification)
  - [Common Amplified Oncogenes](./Chapter%2005:%20Oncogenes.md#common-amplified-oncogenes)
- **5.3.3** [Chromosomal Rearrangements](./Chapter%2005:%20Oncogenes.md#533-chromosomal-rearrangements)
  - [Fusion Oncoproteins](./Chapter%2005:%20Oncogenes.md#fusion-oncoproteins)
  - [Enhancer Hijacking](./Chapter%2005:%20Oncogenes.md#enhancer-hijacking)

</details>

<details>
<summary><strong>5.4 Key Oncogene Families and Their Roles</strong></summary>
<br>

- [View Main Section](./Chapter%2005:%20Oncogenes.md#54-key-oncogene-families-and-their-roles)
- **5.4.1** [RAS Family Oncogenes](./Chapter%2005:%20Oncogenes.md#541-ras-family-oncogenes)
  - [Normal RAS Function](./Chapter%2005:%20Oncogenes.md#normal-ras-function)
  - [RAS in Cancer](./Chapter%2005:%20Oncogenes.md#ras-in-cancer)
- **5.4.2** [Receptor Tyrosine Kinases](./Chapter%2005:%20Oncogenes.md#542-receptor-tyrosine-kinases)
  - [RTK Structure and Function](./Chapter%2005:%20Oncogenes.md#rtk-structure-and-function)
  - [RTK Oncogenes](./Chapter%2005:%20Oncogenes.md#rtk-oncogenes)
- **5.4.3** [Non-Receptor Tyrosine Kinases](./Chapter%2005:%20Oncogenes.md#543-non-receptor-tyrosine-kinases)
  - [ABL Family](./Chapter%2005:%20Oncogenes.md#abl-family)
- **5.4.4** [Transcription Factor Oncogenes](./Chapter%2005:%20Oncogenes.md#544-transcription-factor-oncogenes)
  - [MYC Family](./Chapter%2005:%20Oncogenes.md#myc-family)
  - [Activation Mechanisms](./Chapter%2005:%20Oncogenes.md#activation-mechanisms)

</details>

<details>
<summary><strong>5.5 Clinical Implications and Therapeutic Targeting</strong></summary>
<br>

- [View Main Section](./Chapter%2005:%20Oncogenes.md#55-clinical-implications-and-therapeutic-targeting)
- **5.5.1** [Oncogenes as Drug Targets](./Chapter%2005:%20Oncogenes.md#551-oncogenes-as-drug-targets)
  - [Tyrosine Kinase Inhibitors](./Chapter%2005:%20Oncogenes.md#tyrosine-kinase-inhibitors)
- **5.5.2** [Resistance Mechanisms](./Chapter%2005:%20Oncogenes.md#552-resistance-mechanisms)
- **5.5.3** [Future Directions](./Chapter%2005:%20Oncogenes.md#553-future-directions)

</details>

<details>
<summary><strong>Conclusion</strong></summary>
<br>

- [View Conclusion](./Chapter%2005:%20Oncogenes.md#conclusion)

</details>


## Chapter 6: Tumor Suppressor Genes

<details>
<summary><strong>6.1 Discovery and Function of Tumor Suppressor Genes</strong></summary>
<br>

- [View Main Section](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#61-discovery-and-function-of-tumor-suppressor-genes)
- **6.1.1** [Historical Perspective and Discovery](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#611-historical-perspective-and-discovery)
  - [Cell Fusion Studies](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#cell-fusion-studies)
  - [The Two-Hit Hypothesis](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#the-two-hit-hypothesis)
  - [Molecular Identification of Tumor Suppressors](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#molecular-identification-of-tumor-suppressors)
- **6.1.2** [General Functions of Tumor Suppressor Genes](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#612-general-functions-of-tumor-suppressor-genes)
  - [Cell Cycle Regulation](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#cell-cycle-regulation)
  - [DNA Damage Response and Repair](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#dna-damage-response-and-repair)
  - [Apoptosis Regulation](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#apoptosis-regulation)
- **6.1.3** [Classification and Properties](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#613-classification-and-properties)

</details>

<details>
<summary><strong>6.2 Mechanisms of Tumor Suppressor Inactivation</strong></summary>
<br>

- [View Main Section](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#62-mechanisms-of-tumor-suppressor-inactivation)
- **6.2.1** [Overview of Inactivation Mechanisms](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#621-overview-of-inactivation-mechanisms)
- **6.2.2** [Genetic Mechanisms of Inactivation](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#622-genetic-mechanisms-of-inactivation)
  - [Classical Genetic Alterations](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#classical-genetic-alterations)
  - [Structural Chromosomal Alterations](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#structural-chromosomal-alterations)
  - [Point Mutations and Small Alterations](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#point-mutations-and-small-alterations)
- **6.2.3** [Epigenetic Mechanisms of Inactivation](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#623-epigenetic-mechanisms-of-inactivation)
  - [DNA Methylation](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#dna-methylation)
  - [Histone Modifications](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#histone-modifications)
  - [Chromatin Remodeling](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#chromatin-remodeling)
- **6.2.4** [Viral Mechanisms of Inactivation](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#624-viral-mechanisms-of-inactivation)
- **6.2.5** [Clinical Examples of Inactivation Mechanisms](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#625-clinical-examples-of-inactivation-mechanisms)
  - [p16/CDKN2A Inactivation](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#p16cdkn2a-inactivation)
  - [MLH1 in Colorectal Cancer](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#mlh1-in-colorectal-cancer)

</details>

<details>
<summary><strong>6.3 Key Tumor Suppressor Genes</strong></summary>
<br>

- [View Main Section](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#63-key-tumor-suppressor-genes)
- **6.3.1** [TP53: Guardian of the Genome](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#631-tp53-guardian-of-the-genome)
  - [Structure and Function](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#structure-and-function)
  - [Role in DNA Damage Response](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#role-in-dna-damage-response)
  - [Clinical Significance](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#clinical-significance)
- **6.3.2** [RB1: Master Regulator of the Cell Cycle](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#632-rb1-master-regulator-of-the-cell-cycle)
  - [Normal Function](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#normal-function)
  - [Viral Inactivation](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#viral-inactivation)
- **6.3.3** [BRCA1 and BRCA2: Guardians of Genomic Integrity](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#633-brca1-and-brca2-guardians-of-genomic-integrity)
  - [Molecular Functions](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#molecular-functions)
  - [DNA Repair Functions](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#dna-repair-functions)
  - [Clinical Implications](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#clinical-implications)
  - [Therapeutic Targeting](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#therapeutic-targeting)
- **6.3.4** [APC: The Colorectal Cancer Gatekeeper](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#634-apc-the-colorectal-cancer-gatekeeper)
  - [Role in Colorectal Cancer](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#role-in-colorectal-cancer)
  - [Familial Adenomatous Polyposis](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#familial-adenomatous-polyposis)
  - [Molecular Function](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#molecular-function)
- **6.3.5** [PTEN: A Phosphatase with Broad Tumor Suppressive Functions](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#635-pten-a-phosphatase-with-broad-tumor-suppressive-functions)
  - [Molecular Function](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#molecular-function-1)
  - [PTEN Hamartoma Tumor Syndrome](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#pten-hamartoma-tumor-syndrome)

</details>

<details>
<summary><strong>6.4 Clinical Implications of Tumor Suppressors</strong></summary>
<br>

- [View Main Section](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#64-clinical-implications-of-tumor-suppressors)
- **6.4.1** [Hereditary Cancer Syndromes](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#641-hereditary-cancer-syndromes)
  - [Li-Fraumeni Syndrome](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#li-fraumeni-syndrome)
  - [BRCA-Associated Hereditary Breast and Ovarian Cancer](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#brca-associated-hereditary-breast-and-ovarian-cancer)
- **6.4.2** [Therapeutic Targeting of Tumor Suppressors](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#642-therapeutic-targeting-of-tumor-suppressors)
  - [PARP Inhibitors and Synthetic Lethality](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#parp-inhibitors-and-synthetic-lethality)
  - [Combination Therapy Approaches](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#combination-therapy-approaches)
  - [p53-Targeted Therapies](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#p53-targeted-therapies)
- **6.4.3** [Biomarker Development and Precision Medicine](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#643-biomarker-development-and-precision-medicine)
  - [Homologous Recombination Deficiency Testing](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#homologous-recombination-deficiency-testing)
  - [Expanding Beyond BRCA](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#expanding-beyond-brca)
- **6.4.4** [Diagnostic Applications](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#644-diagnostic-applications)
  - [Methylation-Based Diagnostics](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#methylation-based-diagnostics)
  - [Liquid Biopsy Applications](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#liquid-biopsy-applications)
- **6.4.5** [Therapeutic Resistance and Adaptation](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#645-therapeutic-resistance-and-adaptation)
  - [Epigenetic Therapy Limitations](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#epigenetic-therapy-limitations)

</details>

<details>
<summary><strong>6.5 Future Directions</strong></summary>
<br>

- [View Main Section](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#65-future-directions)
- **6.5.1** [Advanced Molecular Profiling Technologies](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#651-advanced-molecular-profiling-technologies)
  - [Multi-Omics Approaches](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#multi-omics-approaches)
  - [Comprehensive Genomic Profiling](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#comprehensive-genomic-profiling)
- **6.5.2** [Precision Medicine Applications](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#652-precision-medicine-applications)
  - [Biomarker-Driven Treatment Selection](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#biomarker-driven-treatment-selection)
  - [Expanding Therapeutic Targets](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#expanding-therapeutic-targets)
- **6.5.3** [Novel Therapeutic Strategies](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#653-novel-therapeutic-strategies)
  - [Combination Therapy Development](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#combination-therapy-development)
  - [Synthetic Lethality Beyond BRCA](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#synthetic-lethality-beyond-brca)
- **6.5.4** [Emerging Technologies and Approaches](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#654-emerging-technologies-and-approaches)
  - [Functional Assays for Tumor Suppressor Activity](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#functional-assays-for-tumor-suppressor-activity)
  - [Liquid Biopsy Advancements](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#liquid-biopsy-advancements)
- **6.5.5** [Challenges and Future Opportunities](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#655-challenges-and-future-opportunities)
  - [Precision Medicine Implementation](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#precision-medicine-implementation)
  - [Integration of Multiple Data Types](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#integration-of-multiple-data-types)
- **6.5.6** [Therapeutic Resistance and Adaptation](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#656-therapeutic-resistance-and-adaptation)
  - [Understanding Resistance Mechanisms](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#understanding-resistance-mechanisms)
  - [Strategies to Overcome Resistance](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#strategies-to-overcome-resistance)
- **6.5.7** [Future Paradigms in Cancer Treatment](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#657-future-paradigms-in-cancer-treatment)
  - [Precision Oncology Evolution](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#precision-oncology-evolution)
  - [Immunotherapy Integration](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#immunotherapy-integration)
- **6.5.8** [Research Infrastructure and Data Integration](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#658-research-infrastructure-and-data-integration)
  - [Comprehensive Data Analysis](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#comprehensive-data-analysis)
  - [Technology-Driven Discovery](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#technology-driven-discovery)
- **6.5.9** [Therapeutic Development Pipeline](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#659-therapeutic-development-pipeline)
  - [Expanding Treatment Options](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#expanding-treatment-options)

</details>

<details>
<summary><strong>Conclusion</strong></summary>
<br>

- [View Conclusion](./Chapter%2006:%20Tumor%20Suppressor%20Genes.md#conclusion)

</details>

## Chapter 7: Epigenetics in Cancer

<details>
<summary><strong>7.1 Introduction to Epigenetics in Cancer</strong></summary>
<br>

- [View Main Section](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#71-introduction-to-epigenetics-in-cancer)
- **7.1.1** [Definition and Scope](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#711-definition-and-scope)
- **7.1.2** [Fundamental Epigenetic Mechanisms](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#712-fundamental-epigenetic-mechanisms)
- **7.1.3** [Epigenetic Alterations in Cancer](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#713-epigenetic-alterations-in-cancer)

</details>

<details>
<summary><strong>7.2 DNA Methylation in Cancer</strong></summary>
<br>

- [View Main Section](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#72-dna-methylation-in-cancer)
- **7.2.1** [Molecular Basis of DNA Methylation](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#721-molecular-basis-of-dna-methylation)
- **7.2.2** [DNA Methylation Alterations in Cancer](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#722-dna-methylation-alterations-in-cancer)
  - [Genomic Hypomethylation](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#genomic-hypomethylation)
  - [Promoter Hypermethylation](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#promoter-hypermethylation)
- **7.2.3** [Clinical Examples](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#723-clinical-examples)

</details>

<details>
<summary><strong>7.3 Histone Modifications in Cancer</strong></summary>
<br>

- [View Main Section](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#73-histone-modifications-in-cancer)
- **7.3.1** [Basic Mechanisms of Histone Modifications](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#731-basic-mechanisms-of-histone-modifications)
- **7.3.2** [Types of Histone Modifications](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#732-types-of-histone-modifications)
- **7.3.3** [Histone Modifications in Cancer](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#733-histone-modifications-in-cancer)
  - [Clinical Examples in Bladder Cancer](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#clinical-examples-in-bladder-cancer)
- **7.3.4** [Metabolic Regulation of Histone Modifications](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#734-metabolic-regulation-of-histone-modifications)

</details>

<details>
<summary><strong>7.4 Non-coding RNAs in Cancer</strong></summary>
<br>

- [View Main Section](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#74-non-coding-rnas-in-cancer)
- **7.4.1** [Overview of Non-coding RNAs](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#741-overview-of-non-coding-rnas)
- **7.4.2** [MicroRNAs in Cancer](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#742-micrornas-in-cancer)
  - [Structure and Biogenesis](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#structure-and-biogenesis)
  - [Canonical Biogenesis Pathway](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#canonical-biogenesis-pathway)
  - [Clinical Applications](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#clinical-applications)
  - [miRNA-21 as a Biomarker](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#mirna-21-as-a-biomarker)
- **7.4.3** [Long Non-coding RNAs in Cancer](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#743-long-non-coding-rnas-in-cancer)
  - [Historical Context](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#historical-context)
  - [Clinical Significance](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#clinical-significance)

</details>

<details>
<summary><strong>7.5 Polycomb and Trithorax Group Proteins</strong></summary>
<br>

- [View Main Section](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#75-polycomb-and-trithorax-group-proteins)
- **7.5.1** [Cellular Memory Systems](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#751-cellular-memory-systems)
- **7.5.2** [Clinical Relevance in Cancer](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#752-clinical-relevance-in-cancer)
- **7.5.3** [Bivalent Chromatin and Cancer](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#753-bivalent-chromatin-and-cancer)

</details>

<details>
<summary><strong>7.6 Epigenetic Reprogramming in Cancer</strong></summary>
<br>

- [View Main Section](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#76-epigenetic-reprogramming-in-cancer)
- **7.6.1** [Cancer as Epigenetic Disease](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#761-cancer-as-epigenetic-disease)
- **7.6.2** [Epigenetic Changes in Carcinogenesis](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#762-epigenetic-changes-in-carcinogenesis)
- **7.6.3** [Stem Cells and Epigenetic Cancer](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#763-stem-cells-and-epigenetic-cancer)

</details>

<details>
<summary><strong>7.7 Epigenetic Therapy</strong></summary>
<br>

- [View Main Section](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#77-epigenetic-therapy)
- **7.7.1** [Therapeutic Rationale](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#771-therapeutic-rationale)
- **7.7.2** [FDA-Approved Epigenetic Drugs](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#772-fda-approved-epigenetic-drugs)
- **7.7.3** [DNA Methyltransferase Inhibitors](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#773-dna-methyltransferase-inhibitors)
- **7.7.4** [Combination Therapies](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#774-combination-therapies)
- **7.7.5** [Synthetic Lethality Approaches](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#775-synthetic-lethality-approaches)

</details>

<details>
<summary><strong>7.8 Clinical Applications and Future Directions</strong></summary>
<br>

- [View Main Section](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#78-clinical-applications-and-future-directions)
- **7.8.1** [Biomarker Applications](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#781-biomarker-applications)
- **7.8.2** [Personalized Medicine](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#782-personalized-medicine)
- **7.8.3** [Future Research Directions](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#783-future-research-directions)

</details>

<details>
<summary><strong>Conclusion</strong></summary>
<br>

- [View Conclusion](./Chapter%2007:%20Epigenetics%20in%20Cancer.md#conclusion)

</details>


## Chapter 8: Cancer Etiology

<details>
<summary><strong>Introduction</strong></summary>
<br>

- [View Introduction](./Chapter%2008:%20Cancer%20Etiology.md#introduction)

</details>

<details>
<summary><strong>8.1 Chemical Carcinogens</strong></summary>
<br>

- [View Main Section](./Chapter%2008:%20Cancer%20Etiology.md#81-chemical-carcinogens)
- **8.1.1** [Overview and Classification](./Chapter%2008:%20Cancer%20Etiology.md#811-overview-and-classification)
- **8.1.2** [Mechanisms of Chemical Carcinogenesis](./Chapter%2008:%20Cancer%20Etiology.md#812-mechanisms-of-chemical-carcinogenesis)
  - [Initiation, Promotion, and Progression](./Chapter%2008:%20Cancer%20Etiology.md#initiation-promotion-and-progression)
  - [DNA Damage and Repair](./Chapter%2008:%20Cancer%20Etiology.md#dna-damage-and-repair)
- **8.1.3** [Major Classes of Chemical Carcinogens](./Chapter%2008:%20Cancer%20Etiology.md#813-major-classes-of-chemical-carcinogens)
  - [Tobacco Smoke Carcinogens](./Chapter%2008:%20Cancer%20Etiology.md#tobacco-smoke-carcinogens)
  - [Aflatoxins](./Chapter%2008:%20Cancer%20Etiology.md#aflatoxins)
  - [N-Nitroso Compounds](./Chapter%2008:%20Cancer%20Etiology.md#n-nitroso-compounds)
  - [Dietary Carcinogens](./Chapter%2008:%20Cancer%20Etiology.md#dietary-carcinogens)
- **8.1.4** [Risk Assessment and Prevention](./Chapter%2008:%20Cancer%20Etiology.md#814-risk-assessment-and-prevention)

</details>

<details>
<summary><strong>8.2 Radiation Carcinogenesis</strong></summary>
<br>

- [View Main Section](./Chapter%2008:%20Cancer%20Etiology.md#82-radiation-carcinogenesis)
- **8.2.1** [Types of Radiation](./Chapter%2008:%20Cancer%20Etiology.md#821-types-of-radiation)
  - [Ionizing Radiation](./Chapter%2008:%20Cancer%20Etiology.md#ionizing-radiation)
  - [Ultraviolet Radiation](./Chapter%2008:%20Cancer%20Etiology.md#ultraviolet-radiation)
- **8.2.2** [Mechanisms of Radiation Carcinogenesis](./Chapter%2008:%20Cancer%20Etiology.md#822-mechanisms-of-radiation-carcinogenesis)
  - [DNA Damage](./Chapter%2008:%20Cancer%20Etiology.md#dna-damage)
  - [Genomic Instability](./Chapter%2008:%20Cancer%20Etiology.md#genomic-instability)
- **8.2.3** [Evidence from Human Studies](./Chapter%2008:%20Cancer%20Etiology.md#823-evidence-from-human-studies)
  - [Atomic Bomb Survivors](./Chapter%2008:%20Cancer%20Etiology.md#atomic-bomb-survivors)
  - [UV Radiation and Skin Cancer](./Chapter%2008:%20Cancer%20Etiology.md#uv-radiation-and-skin-cancer)
  - [Experimental Evidence](./Chapter%2008:%20Cancer%20Etiology.md#experimental-evidence)
- **8.2.4** [Dose-Response Relationships](./Chapter%2008:%20Cancer%20Etiology.md#824-dose-response-relationships)

</details>

<details>
<summary><strong>8.3 Viral Carcinogenesis</strong></summary>
<br>

- [View Main Section](./Chapter%2008:%20Cancer%20Etiology.md#83-viral-carcinogenesis)
- **8.3.1** [Overview of Oncogenic Viruses](./Chapter%2008:%20Cancer%20Etiology.md#831-overview-of-oncogenic-viruses)
  - [Major Oncogenic Viruses](./Chapter%2008:%20Cancer%20Etiology.md#major-oncogenic-viruses)
- **8.3.2** [Human Papillomaviruses (HPV)](./Chapter%2008:%20Cancer%20Etiology.md#832-human-papillomaviruses-hpv)
  - [Virus Characteristics](./Chapter%2008:%20Cancer%20Etiology.md#virus-characteristics)
  - [Mechanisms of HPV Carcinogenesis](./Chapter%2008:%20Cancer%20Etiology.md#mechanisms-of-hpv-carcinogenesis)
  - [Clinical Significance](./Chapter%2008:%20Cancer%20Etiology.md#clinical-significance)
- **8.3.3** [Hepatitis Viruses](./Chapter%2008:%20Cancer%20Etiology.md#833-hepatitis-viruses)
  - [Hepatitis B Virus (HBV)](./Chapter%2008:%20Cancer%20Etiology.md#hepatitis-b-virus-hbv)
  - [Prevention and Treatment](./Chapter%2008:%20Cancer%20Etiology.md#prevention-and-treatment)
- **8.3.4** [Other Oncogenic Viruses](./Chapter%2008:%20Cancer%20Etiology.md#834-other-oncogenic-viruses)
  - [Epstein-Barr Virus (EBV)](./Chapter%2008:%20Cancer%20Etiology.md#epstein-barr-virus-ebv)
  - [Immunosuppression and Viral Carcinogenesis](./Chapter%2008:%20Cancer%20Etiology.md#immunosuppression-and-viral-carcinogenesis)

</details>

<details>
<summary><strong>8.4 Bacterial Carcinogenesis</strong></summary>
<br>

- [View Main Section](./Chapter%2008:%20Cancer%20Etiology.md#84-bacterial-carcinogenesis)
- **8.4.1** [Helicobacter pylori and Gastric Cancer](./Chapter%2008:%20Cancer%20Etiology.md#841-helicobacter-pylori-and-gastric-cancer)
  - [Epidemiology and Disease Associations](./Chapter%2008:%20Cancer%20Etiology.md#epidemiology-and-disease-associations)
  - [Mechanisms of H. pylori Carcinogenesis](./Chapter%2008:%20Cancer%20Etiology.md#mechanisms-of-h-pylori-carcinogenesis)
  - [Inflammatory Response](./Chapter%2008:%20Cancer%20Etiology.md#inflammatory-response)
  - [Virulence Factors](./Chapter%2008:%20Cancer%20Etiology.md#virulence-factors)
  - [Animal Models](./Chapter%2008:%20Cancer%20Etiology.md#animal-models)
- **8.4.2** [Prevention and Treatment](./Chapter%2008:%20Cancer%20Etiology.md#842-prevention-and-treatment)
  - [Eradication Therapy](./Chapter%2008:%20Cancer%20Etiology.md#eradication-therapy)
  - [Risk Assessment](./Chapter%2008:%20Cancer%20Etiology.md#risk-assessment)
- **8.4.3** [The Microbiome and Cancer](./Chapter%2008:%20Cancer%20Etiology.md#843-the-microbiome-and-cancer)

</details>

<details>
<summary><strong>8.5 Multifactorial Nature of Carcinogenesis</strong></summary>
<br>

- [View Main Section](./Chapter%2008:%20Cancer%20Etiology.md#85-multifactorial-nature-of-carcinogenesis)
- **8.5.1** [The Hallmarks of Cancer](./Chapter%2008:%20Cancer%20Etiology.md#851-the-hallmarks-of-cancer)
- **8.5.2** [Co-factors and Risk Modifiers](./Chapter%2008:%20Cancer%20Etiology.md#852-co-factors-and-risk-modifiers)
  - [Hormones and Promotion](./Chapter%2008:%20Cancer%20Etiology.md#hormones-and-promotion)
  - [Environmental Co-factors](./Chapter%2008:%20Cancer%20Etiology.md#environmental-co-factors)
- **8.5.3** [Prevention Strategies](./Chapter%2008:%20Cancer%20Etiology.md#853-prevention-strategies)
  - [Primary Prevention](./Chapter%2008:%20Cancer%20Etiology.md#primary-prevention)
  - [Secondary Prevention](./Chapter%2008:%20Cancer%20Etiology.md#secondary-prevention)

</details>

<details>
<summary><strong>Conclusion</strong></summary>
<br>

- [View Conclusion](./Chapter%2008:%20Cancer%20Etiology.md#conclusion)

</details>

# Part III: Tumor Progression and Microenvironment

## Chapter 9: [Cell Cycle Control and Cancer](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md)

### [Introduction](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#introduction)

### 9.1 [Overview of the Cell Cycle and Its Regulation](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#91-overview-of-the-cell-cycle-and-its-regulation)
- **9.1.1** [Cell Cycle Phases](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#911-cell-cycle-phases)
- **9.1.2** [Core Components of Cell Cycle Control](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#912-core-components-of-cell-cycle-control)
  - [Cyclin-Dependent Kinases (CDKs)](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#cyclin-dependent-kinases-cdks)
  - [Cyclin Classification](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#cyclin-classification)
  - [Cell Cycle Progression Overview](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#cell-cycle-progression-overview)

### 9.2 [Cell Cycle Checkpoints](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#92-cell-cycle-checkpoints)
- **9.2.1** [The Concept of Cell Cycle Checkpoints](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#921-the-concept-of-cell-cycle-checkpoints)
- **9.2.2** [The Restriction Point](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#922-the-restriction-point)
  - [Molecular Control of the Restriction Point](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#molecular-control-of-the-restriction-point)
- **9.2.3** [DNA Damage Checkpoints](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#923-dna-damage-checkpoints)
  - [DNA Damage Response Pathways](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#dna-damage-response-pathways)
- **9.2.4** [The G2/M Checkpoint](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#924-the-g2m-checkpoint)
  - [Mitotic Promoting Factor (MPF)](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#mitotic-promoting-factor-mpf)

### 9.3 [Cyclin-Dependent Kinase Inhibitors](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#93-cyclin-dependent-kinase-inhibitors)
- **9.3.1** [Families of CDK Inhibitors](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#931-families-of-cdk-inhibitors)
  - [Anti-proliferative Signaling](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#anti-proliferative-signaling)

### 9.4 [Tumor Suppressor Genes](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#94-tumor-suppressor-genes)
- **9.4.1** [The p53 Tumor Suppressor](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#941-the-p53-tumor-suppressor)
  - [p53 Function and Regulation](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#p53-function-and-regulation)
  - [p53 Pathway Mechanism](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#p53-pathway-mechanism)
  - [p53 Target Genes](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#p53-target-genes)
  - [p53 Regulation by MDM2](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#p53-regulation-by-mdm2)
- **9.4.2** [The Retinoblastoma (Rb) Tumor Suppressor](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#942-the-retinoblastoma-rb-tumor-suppressor)
  - [Rb Function in Cell Cycle Control](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#rb-function-in-cell-cycle-control)
  - [Rb and Cancer](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#rb-and-cancer)

### 9.5 [Oncogenes and Cell Cycle Dysregulation](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#95-oncogenes-and-cell-cycle-dysregulation)
- **9.5.1** [Proto-oncogenes and Oncogenes](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#951-proto-oncogenes-and-oncogenes)
- **9.5.2** [Mechanisms of Oncogene Activation](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#952-mechanisms-of-oncogene-activation)
  - [Gene Amplification](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#gene-amplification)
  - [Chromosomal Rearrangements and Mutations](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#chromosomal-rearrangements-and-mutations)
- **9.5.3** [Growth Factor Signaling and Cell Cycle](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#953-growth-factor-signaling-and-cell-cycle)
  - [Oncogenic Stress Response](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#oncogenic-stress-response)

### 9.6 [Disruption of Cell Cycle Control in Cancer](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#96-disruption-of-cell-cycle-control-in-cancer)
- **9.6.1** [Common Alterations in Cancer](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#961-common-alterations-in-cancer)
  - [p53 Mutations in Cancer](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#p53-mutations-in-cancer)
- **9.6.2** [Viral Oncoproteins and Cell Cycle Control](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#962-viral-oncoproteins-and-cell-cycle-control)
- **9.6.3** [Multistep Carcinogenesis](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#963-multistep-carcinogenesis)
- **9.6.4** [Consequences of Cell Cycle Disruption](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#964-consequences-of-cell-cycle-disruption)
  - [Genomic Instability](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#genomic-instability)
  - [Unlimited Proliferative Potential](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#unlimited-proliferative-potential)

### 9.7 [Therapeutic Implications](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#97-therapeutic-implications)
- **9.7.1** [Targeting Cell Cycle Checkpoints](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#971-targeting-cell-cycle-checkpoints)
- **9.7.2** [CDK Inhibitors as Cancer Therapeutics](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#972-cdk-inhibitors-as-cancer-therapeutics)

### [Conclusion](./Chapter%2009:%20Cell%20Cycle%20Control%20and%20Cancer.md#conclusion)

## Chapter 10: [Apoptosis and Programmed Cell Death in Cancer](./Chapter%2010:%20Apoptosis%20and%20Programmed%20Cell%20Death%20in%20Cancer.md)

### 10.1 [Pathways of Apoptosis: Intrinsic and Extrinsic](./Chapter%2010:%20Apoptosis%20and%20Programmed%20Cell%20Death%20in%20Cancer.md#101-pathways-of-apoptosis-intrinsic-and-extrinsic)
- **10.1.1** [The Intrinsic Apoptotic Pathway](./Chapter%2010:%20Apoptosis%20and%20Programmed%20Cell%20Death%20in%20Cancer.md#1011-the-intrinsic-apoptotic-pathway)
- **10.1.2** [The Extrinsic Apoptotic Pathway](./Chapter%2010:%20Apoptosis%20and%20Programmed%20Cell%20Death%20in%20Cancer.md#1012-the-extrinsic-apoptotic-pathway)
- **10.1.3** [Convergence and Cross-talk Between Pathways](./Chapter%2010:%20Apoptosis%20and%20Programmed%20Cell%20Death%20in%20Cancer.md#1013-convergence-and-cross-talk-between-pathways)

### 10.2 [Evasion of Apoptosis by Cancer Cells](./Chapter%2010:%20Apoptosis%20and%20Programmed%20Cell%20Death%20in%20Cancer.md#102-evasion-of-apoptosis-by-cancer-cells)
- **10.2.1** [Dysregulation of Bcl-2 Family Proteins](./Chapter%2010:%20Apoptosis%20and%20Programmed%20Cell%20Death%20in%20Cancer.md#1021-dysregulation-of-bcl-2-family-proteins)
  - [Mechanisms of Bcl-2 Dysregulation](./Chapter%2010:%20Apoptosis%20and%20Programmed%20Cell%20Death%20in%20Cancer.md#mechanisms-of-bcl-2-dysregulation)
- **10.2.2** [p53 Mutations and Apoptosis Evasion](./Chapter%2010:%20Apoptosis%20and%20Programmed%20Cell%20Death%20in%20Cancer.md#1022-p53-mutations-and-apoptosis-evasion)
  - [p53-Mediated Apoptosis](./Chapter%2010:%20Apoptosis%20and%20Programmed%20Cell%20Death%20in%20Cancer.md#p53-mediated-apoptosis)
- **10.2.3** [Inhibitor of Apoptosis Proteins (IAPs)](./Chapter%2010:%20Apoptosis%20and%20Programmed%20Cell%20Death%20in%20Cancer.md#1023-inhibitor-of-apoptosis-proteins-iaps)
- **10.2.4** [Death Receptor Pathway Resistance](./Chapter%2010:%20Apoptosis%20and%20Programmed%20Cell%20Death%20in%20Cancer.md#1024-death-receptor-pathway-resistance)

### 10.3 [Therapeutic Targeting of Apoptosis](./Chapter%2010:%20Apoptosis%20and%20Programmed%20Cell%20Death%20in%20Cancer.md#103-therapeutic-targeting-of-apoptosis)
- **10.3.1** [BCL-2 Inhibitors and BH3 Mimetics](./Chapter%2010:%20Apoptosis%20and%20Programmed%20Cell%20Death%20in%20Cancer.md#1031-bcl-2-inhibitors-and-bh3-mimetics)
  - [Clinical Development](./Chapter%2010:%20Apoptosis%20and%20Programmed%20Cell%20Death%20in%20Cancer.md#clinical-development)
- **10.3.2** [IAP Antagonists](./Chapter%2010:%20Apoptosis%20and%20Programmed%20Cell%20Death%20in%20Cancer.md#1032-iap-antagonists)
- **10.3.3** [TRAIL and Death Receptor Agonists](./Chapter%2010:%20Apoptosis%20and%20Programmed%20Cell%20Death%20in%20Cancer.md#1033-trail-and-death-receptor-agonists)
- **10.3.4** [p53 Restoration Strategies](./Chapter%2010:%20Apoptosis%20and%20Programmed%20Cell%20Death%20in%20Cancer.md#1034-p53-restoration-strategies)
  - [Therapeutic Approaches](./Chapter%2010:%20Apoptosis%20and%20Programmed%20Cell%20Death%20in%20Cancer.md#therapeutic-approaches)
- **10.3.5** [Combination Therapies and Resistance](./Chapter%2010:%20Apoptosis%20and%20Programmed%20Cell%20Death%20in%20Cancer.md#1035-combination-therapies-and-resistance)
  - [Clinical Significance](./Chapter%2010:%20Apoptosis%20and%20Programmed%20Cell%20Death%20in%20Cancer.md#clinical-significance)

### [Summary](./Chapter%2010:%20Apoptosis%20and%20Programmed%20Cell%20Death%20in%20Cancer.md#summary)

## Chapter 11: [Cancer Metabolism: The Warburg Effect and Beyond](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md)

### [Introduction](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#introduction)

### 11.1 [The Warburg Effect: Historical Discovery and Modern Understanding](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#111-the-warburg-effect-historical-discovery-and-modern-understanding)
- **11.1.1** [Historical Perspective](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#1111-historical-perspective)
- **11.1.2** [Contemporary Understanding](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#1112-contemporary-understanding)
  - [Efficiency and Kinetics](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#efficiency-and-kinetics)
  - [Anabolic Requirements](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#anabolic-requirements)
  - [Clinical Applications](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#clinical-applications)
- **11.1.3** [Metabolic Heterogeneity](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#1113-metabolic-heterogeneity)

### 11.2 [Glucose Metabolism in Cancer](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#112-glucose-metabolism-in-cancer)
- **11.2.1** [Glycolytic Pathway Regulation](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#1121-glycolytic-pathway-regulation)
  - [Basic Glycolysis Pathway](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#basic-glycolysis-pathway)
  - [Enhanced Glycolysis in Cancer](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#enhanced-glycolysis-in-cancer)
- **11.2.2** [The Reverse Warburg Effect](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#1122-the-reverse-warburg-effect)
- **11.2.3** [Therapeutic Targeting of Glucose Metabolism](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#1123-therapeutic-targeting-of-glucose-metabolism)

### 11.3 [Mitochondrial Function in Cancer](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#113-mitochondrial-function-in-cancer)
- **11.3.1** [Mitochondrial Structure and Function](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#1131-mitochondrial-structure-and-function)
- **11.3.2** [Mitochondria in Cancer Metabolism](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#1132-mitochondria-in-cancer-metabolism)
  - [Energy Production](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#energy-production)
  - [Metabolic Integration](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#metabolic-integration)
- **11.3.3** [Mitochondrial Protein Import and Assembly](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#1133-mitochondrial-protein-import-and-assembly)

### 11.4 [Lipid Metabolism in Cancer](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#114-lipid-metabolism-in-cancer)
- **11.4.1** [Fatty Acid Synthesis and Cancer](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#1141-fatty-acid-synthesis-and-cancer)
  - [De Novo Lipid Synthesis](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#de-novo-lipid-synthesis)
  - [Enzyme Regulation](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#enzyme-regulation)
- **11.4.2** [Fatty Acid Oxidation](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#1142-fatty-acid-oxidation)
- **11.4.3** [Cancer-Associated Fibroblasts and Lipid Metabolism](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#1143-cancer-associated-fibroblasts-and-lipid-metabolism)

### 11.5 [Amino Acid Metabolism in Cancer](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#115-amino-acid-metabolism-in-cancer)
- **11.5.1** [Glutamine Metabolism](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#1151-glutamine-metabolism)
  - [Glutamine as a Critical Nutrient](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#glutamine-as-a-critical-nutrient)
  - [Glutaminolysis Pathway](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#glutaminolysis-pathway)
- **11.5.2** [Serine and Glycine Metabolism](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#1152-serine-and-glycine-metabolism)
- **11.5.3** [Therapeutic Targeting of Amino Acid Metabolism](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#1153-therapeutic-targeting-of-amino-acid-metabolism)
  - [Glutaminase Inhibition](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#glutaminase-inhibition)

### 11.6 [Metabolic Interactions in the Tumor Microenvironment](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#116-metabolic-interactions-in-the-tumor-microenvironment)
- **11.6.1** [Cancer-Associated Fibroblasts (CAFs)](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#1161-cancer-associated-fibroblasts-cafs)
- **11.6.2** [Metabolic Cross-Talk](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#1162-metabolic-cross-talk)
  - [Lactate Shuttle](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#lactate-shuttle)
  - [Mitochondrial Transfer](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#mitochondrial-transfer)
- **11.6.3** [Alanine Metabolism](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#1163-alanine-metabolism)

### 11.7 [Therapeutic Targeting of Cancer Metabolism](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#117-therapeutic-targeting-of-cancer-metabolism)
- **11.7.1** [Targeting Glycolysis](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#1171-targeting-glycolysis)
- **11.7.2** [Targeting Lipid Metabolism](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#1172-targeting-lipid-metabolism)
- **11.7.3** [Combination Strategies](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#1173-combination-strategies)
  - [Metabolic Inhibitor Combinations](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#metabolic-inhibitor-combinations)
  - [Targeting CAF-Cancer Interactions](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#targeting-caf-cancer-interactions)
- **11.7.4** [Challenges in Metabolic Targeting](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#1174-challenges-in-metabolic-targeting)
  - [Drug Resistance and Metabolism](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#drug-resistance-and-metabolism)
  - [Tumor Microenvironment Factors](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#tumor-microenvironment-factors)

### 11.8 [Future Directions and Clinical Translation](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#118-future-directions-and-clinical-translation)
- **11.8.1** [Personalized Metabolic Therapy](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#1181-personalized-metabolic-therapy)
- **11.8.2** [Integration with Other Treatment Modalities](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#1182-integration-with-other-treatment-modalities)
- **11.8.3** [Systems Biology Approaches](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#1183-systems-biology-approaches)

### [Conclusion](./Chapter%2011:%20Cancer%20Metabolism:%20The%20Warburg%20Effect%20and%20Beyond.md#conclusion)

## Chapter 12: [Angiogenesis](./Chapter%2012:%20Angiogenesis.md)

### 12.1 [Introduction and Basic Concepts](./Chapter%2012:%20Angiogenesis.md#121-introduction-and-basic-concepts)
- **12.1.1** [The Angiogenic Switch](./Chapter%2012:%20Angiogenesis.md#1211-the-angiogenic-switch)
- **12.1.2** [Normal versus Pathological Angiogenesis](./Chapter%2012:%20Angiogenesis.md#1212-normal-versus-pathological-angiogenesis)
- **12.1.3** [Tumor Size Limitations and the Angiogenic Switch](./Chapter%2012:%20Angiogenesis.md#1213-tumor-size-limitations-and-the-angiogenic-switch)

### 12.2 [Key Angiogenic Factors](./Chapter%2012:%20Angiogenesis.md#122-key-angiogenic-factors)
- **12.2.1** [Vascular Endothelial Growth Factor (VEGF)](./Chapter%2012:%20Angiogenesis.md#1221-vascular-endothelial-growth-factor-vegf)
  - [VEGF Structure and Isoforms](./Chapter%2012:%20Angiogenesis.md#vegf-structure-and-isoforms)
  - [VEGF Receptors and Signaling](./Chapter%2012:%20Angiogenesis.md#vegf-receptors-and-signaling)
- **12.2.2** [Angiopoietin-Tie System](./Chapter%2012:%20Angiogenesis.md#1222-angiopoietin-tie-system)
  - [Tie Receptors and Angiopoietin Ligands](./Chapter%2012:%20Angiogenesis.md#tie-receptors-and-angiopoietin-ligands)
  - [Angiopoietin Functions in Angiogenesis](./Chapter%2012:%20Angiogenesis.md#angiopoietin-functions-in-angiogenesis)
- **12.2.3** [Other Angiogenic Factors](./Chapter%2012:%20Angiogenesis.md#1223-other-angiogenic-factors)
  - [Fibroblast Growth Factors](./Chapter%2012:%20Angiogenesis.md#fibroblast-growth-factors)
  - [Placental Growth Factor](./Chapter%2012:%20Angiogenesis.md#placental-growth-factor)

### 12.3 [Role of Hypoxia in Angiogenesis](./Chapter%2012:%20Angiogenesis.md#123-role-of-hypoxia-in-angiogenesis)
- **12.3.1** [Hypoxia as an Angiogenic Stimulus](./Chapter%2012:%20Angiogenesis.md#1231-hypoxia-as-an-angiogenic-stimulus)
- **12.3.2** [Hypoxia-Inducible Factors (HIFs)](./Chapter%2012:%20Angiogenesis.md#1232-hypoxia-inducible-factors-hifs)
- **12.3.3** [HIF-Mediated Effects on Tumor Biology](./Chapter%2012:%20Angiogenesis.md#1233-hif-mediated-effects-on-tumor-biology)

### 12.4 [Angiogenic Process and Stages](./Chapter%2012:%20Angiogenesis.md#124-angiogenic-process-and-stages)
- **12.4.1** [Basic Steps of Angiogenesis](./Chapter%2012:%20Angiogenesis.md#1241-basic-steps-of-angiogenesis)
- **12.4.2** [Endothelial Cell Sprouting](./Chapter%2012:%20Angiogenesis.md#1242-endothelial-cell-sprouting)
- **12.4.3** [Tip Cell and Stalk Cell Specification](./Chapter%2012:%20Angiogenesis.md#1243-tip-cell-and-stalk-cell-specification)
- **12.4.4** [Types of Angiogenesis](./Chapter%2012:%20Angiogenesis.md#1244-types-of-angiogenesis)

### 12.5 [Angiogenesis in Cancer](./Chapter%2012:%20Angiogenesis.md#125-angiogenesis-in-cancer)
- **12.5.1** [Historical Perspective](./Chapter%2012:%20Angiogenesis.md#1251-historical-perspective)
- **12.5.2** [Evidence for Angiogenesis Dependence](./Chapter%2012:%20Angiogenesis.md#1252-evidence-for-angiogenesis-dependence)
- **12.5.3** [Tumor-Associated Macrophages and Angiogenesis](./Chapter%2012:%20Angiogenesis.md#1253-tumor-associated-macrophages-and-angiogenesis)
- **12.5.4** [Tumor Angiogenesis in Specific Cancer Types](./Chapter%2012:%20Angiogenesis.md#1254-tumor-angiogenesis-in-specific-cancer-types)

### 12.6 [Anti-Angiogenic Therapy](./Chapter%2012:%20Angiogenesis.md#126-anti-angiogenic-therapy)
- **12.6.1** [Therapeutic Rationale](./Chapter%2012:%20Angiogenesis.md#1261-therapeutic-rationale)
- **12.6.2** [Bevacizumab: Clinical Implementation](./Chapter%2012:%20Angiogenesis.md#1262-bevacizumab-clinical-implementation)
- **12.6.3** [Clinical Efficacy of Anti-Angiogenic Therapy](./Chapter%2012:%20Angiogenesis.md#1263-clinical-efficacy-of-anti-angiogenic-therapy)
- **12.6.4** [Toxicities of Anti-Angiogenic Therapy](./Chapter%2012:%20Angiogenesis.md#1264-toxicities-of-anti-angiogenic-therapy)
- **12.6.5** [Endogenous Angiogenesis Inhibitors](./Chapter%2012:%20Angiogenesis.md#1265-endogenous-angiogenesis-inhibitors)

### 12.7 [Clinical Implications and Future Directions](./Chapter%2012:%20Angiogenesis.md#127-clinical-implications-and-future-directions)
- **12.7.1** [Prognostic Significance](./Chapter%2012:%20Angiogenesis.md#1271-prognostic-significance)
- **12.7.2** [Combination Therapies](./Chapter%2012:%20Angiogenesis.md#1272-combination-therapies)
- **12.7.3** [Emerging Targets](./Chapter%2012:%20Angiogenesis.md#1273-emerging-targets)

### [Conclusion](./Chapter%2012:%20Angiogenesis.md#conclusion)
